海外の治験の状況「1」での検索結果
2290件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Apple Women's Health Study
- Menstrual Cycle;Ovulation;Menstruation;Polycystic Ovary Syndrome;Infertility;Menopause;Reproduction;Reproductive Health
- United States
- 2019-11-13
Recruiting
- Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
- Stargardt Disease;Stargardt Macular Degeneration;Stargardt Macular Dystrophy;Autosomal Recessive Stargardt Disease 1 (ABCA4-related)
- United States
- 2020-01-11
Recruiting
- Congenital Muscle Disease Study of Patient and Family Reported Medical Information
- Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed);Dystroglycanopathy;Congenital Fiber Type Disproportion;Rigid Spine Muscular Dystrophy;Congenital Myopathy (Including Unspecified/Undiagnosed);Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy);Laminin Alpha 2 Related Congenital Muscular Dystrophy;LAMA2-CMD/Merosin Deficient/MDC1A;Walker-Warburg Syndrome;Muscle-Eye-Brain Disease;Fukuyama/Fukutin Related Muscular Dystrophy;Integrin Alpha 7 Deficiency;Integrin Alpha 9 Deficiency;LMNA-CMD/Lamin A/C/Laminopathy;SEPN1-Related Myopathy;Bethlem Myopathy;Actin Aggregation Myopathy;Cap Disease;Central Core Disease;Centronuclear Myopathy;Core Rod Myopathy;Hyaline Body Myopathy;Multiminicore Myopathy;Myotubular Myopathy;Nemaline Myopathy;Tubular Aggregate Myopathy;Zebra Body Myopathy;Reducing Body Myopathy;Spheroid Body Myopathy;LGMD1B (LMNA);LGMD1E (DES);LGMD2G (TCAP);LGMD2H (TRIM32);LGMD2I (FKRP);LGMD2J (TTN);LGMD2K (POMT1);LGMD2M (FKTN);LGMD2N (POMT2);LGMD2O (POMGnT1);LGMD2P (DAG1);LGMD2Q (PLEC1);LGMD2R (DES);LGMD2S (TRAPPC11);LGMD2T (GMPPB);LGMD2U (ISPD);LGMD2V (GAA);Ullrich Congenital Muscular Dystrophy;Titinopathy;Choline Kinase B Receptor;Emery-Dreifuss Muscular Dystrophy;RYR1 Related Myopathy;SYNE1/Nesprin Related Muscular Dystrophy;Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap);Congenital Myasthenic Syndrome;Escobar Syndrome;Myofibrillar Myopathy;Malignant Hyperthermia;Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN);Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1);Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other);Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed);Dystroglycanopathy;Congenital Fiber Type Disproportion;Rigid Spine Muscular Dystrophy;Congenital Myopathy (Including Unspecified/Undiagnosed);Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy);Laminin Alpha 2 Related Congenital Muscular Dystrophy;LAMA2-CMD/Merosin Deficient/MDC1A;Walker-Warburg Syndrome;Muscle-Eye-Brain Disease;Fukuyama/Fukutin Related Muscular Dystrophy;Integrin Alpha 7 Deficiency;Integrin Alpha 9 Deficiency;LMNA-CMD/Lamin A/C/Laminopathy;SEPN1-Related Myopathy;Bethlem Myopathy;Actin Aggregation Myopathy;Cap Disease;Central Core Disease;Centronuclear Myopathy;Core Rod Myopathy;Hyaline Body Myopathy;Multiminicore Myopathy;Myotubular Myopathy;Nemaline Myopathy;Tubular Aggregate Myopathy;Zebra Body Myopathy;Reducing Body Myopathy;Spheroid Body Myopathy;LGMD1B (LMNA);LGMD1E (DES);LGMD2G (TCAP);LGMD2H (TRIM32);LGMD2I (FKRP);LGMD2J (TTN);LGMD2K (POMT1);LGMD2M (FKTN);LGMD2N (POMT2);LGMD2O (POMGnT1);LGMD2P (DAG1);LGMD2Q (PLEC1);LGMD2R (DES);LGMD2S (TRAPPC11);LGMD2T (GMPPB);LGMD2U (ISPD);LGMD2V (GAA);Ullrich Congenital Muscular Dystrophy;Titinopathy;Choline Kinase B Receptor;Emery-Dreifuss Muscular Dystrophy;RYR1 Related Myopathy;SYNE1/Nesprin Related Muscular Dystrophy;Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap);Congenital Myasthenic Syndrome;Escobar Syndrome;Myofibrillar Myopathy;Malignant Hyperthermia;Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN);Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1);Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other);Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed);Dystroglycanopathy;Congenital Fiber Type Disproportion;Rigid Spine Muscular Dystrophy;Congenital Myopathy (Including Unspecified/Undiagnosed);Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy);Laminin Alpha 2 Related Congenital Muscular Dystrophy;LAMA2-CMD/Merosin Deficient/MDC1A;Walker-Warburg Syndrome;Muscle-Eye-Brain Disease;Fukuyama/Fukutin Related Muscular Dystrophy;Integrin Alpha 7 Deficiency;Integrin Alpha 9 Deficiency;LMNA-CMD/Lamin A/C/Laminopathy;SEPN1-Related Myopathy;Bethlem Myopathy;Actin Aggregation Myopathy;Cap Disease;Central Core Disease;Centronuclear Myopathy;Core Rod Myopathy;Hyaline Body Myopathy;Multiminicore Myopathy;Myotubular Myopathy;Nemaline Myopathy;Tubular Aggregate Myopathy;Zebra Body Myopathy;Reducing Body Myopathy;Spheroid Body Myopathy;LGMD1B (LMNA);LGMD1E (DES);LGMD2G (TCAP);LGMD2H (TRIM32);LGMD2I (FKRP);LGMD2J (TTN);LGMD2K (POMT1);LGMD2M (FKTN);LGMD2N (POMT2);LGMD2O (POMGnT1);LGMD2P (DAG1);LGMD2Q (PLEC1);LGMD2R (DES);LGMD2S (TRAPPC11);LGMD2T (GMPPB);LGMD2U (ISPD);LGMD2V (GAA);Ullrich Congenital Muscular Dystrophy;Titinopathy;Choline Kinase B Receptor;Emery-Dreifuss Muscular Dystrophy;RYR1 Related Myopathy;SYNE1/Nesprin Related Muscular Dystrophy;Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap);Congenital Myasthenic Syndrome;Escobar Syndrome;Myofibrillar Myopathy;Malignant Hyperthermia;Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN);Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1);Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other);Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed);Dystroglycanopathy;Congenital Fiber Type Disproportion;Rigid Spine Muscular Dystrophy;Congenital Myopathy (Including Unspecified/Undiagnosed);Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy);Laminin Alpha 2 Related Congenital Muscular Dystrophy;LAMA2-CMD/Merosin Deficient/MDC1A;Walker-Warburg Syndrome;Muscle-Eye-Brain Disease;Fukuyama/Fukutin Related Muscular Dystrophy;Integrin Alpha 7 Deficiency;Integrin Alpha 9 Deficiency;LMNA-CMD/Lamin A/C/Laminopathy;SEPN1-Related Myopathy;Bethlem Myopathy;Actin Aggregation Myopathy;Cap Disease;Central Core Disease;Centronuclear Myopathy;Core Rod Myopathy;Hyaline Body Myopathy;Multiminicore Myopathy;Myotubular Myopathy;Nemaline Myopathy;Tubular Aggregate Myopathy;Zebra Body Myopathy;Reducing Body Myopathy;Spheroid Body Myopathy;LGMD1B (LMNA);LGMD1E (DES);LGMD2G (TCAP);LGMD2H (TRIM32);LGMD2I (FKRP);LGMD2J (TTN);LGMD2K (POMT1);LGMD2M (FKTN);LGMD2N (POMT2);LGMD2O (POMGnT1);LGMD2P (DAG1);LGMD2Q (PLEC1);LGMD2R (DES);LGMD2S (TRAPPC11);LGMD2T (GMPPB);LGMD2U (ISPD);LGMD2V (GAA);Ullrich Congenital Muscular Dystrophy;Titinopathy;Choline Kinase B Receptor;Emery-Dreifuss Muscular Dystrophy;RYR1 Related Myopathy;SYNE1/Nesprin Related Muscular Dystrophy;Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap);Congenital Myasthenic Syndrome;Escobar Syndrome;Myofibrillar Myopathy;Malignant Hyperthermia;Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN);Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1);Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other)
- United States
- 2011-07-26
Recruiting
- Familial Investigations of Childhood Cancer Predisposition
- Acute Leukemia;Adenomatous Polyposis;Adrenocortical Carcinoma;AML;BAP1 Tumor Predisposition Syndrome;Carney Complex;Choroid Plexus Carcinoma;Constitutional Mismatch Repair Deficiency Syndrome;Diamond-Blackfan Anemia;DICER1 Syndrome;Dyskeratosis Congenita;Emberger Syndrome;Familial Acute Myeloid Leukemia;Familial Adenomatous Polyposis;Fanconi Anemia;Familial Cancer;Familial Wilms Tumor;Familial Neuroblastoma;GIST;Hereditary Breast and Ovarian Cancer;Hereditary Paraganglioma-Pheochromocytoma Syndrome;Hodgkin Lymphoma;Juvenile Polyposis;Li-Fraumeni Syndrome;Lynch Syndrome;MDS;Melanoma Syndrome;Multiple Endocrine Neoplasia Type 1;Multiple Endocrine Neoplasia Type 2;Neuroblastoma;Neurofibromatosis Type 1;Neurofibromatosis Type II;Nevoid Basal Cell Carcinoma Syndrome;Non Hodgkin Lymphoma;Noonan Syndrome and Other Rasopathy;Overgrowth Syndromes;Pancreatic Cancer;Peutz-Jeghers Syndrome;Pheochromocytoma/Paraganglioma;PTEN Hamartoma Tumor Syndrome;Retinoblastoma;Rhabdoid Tumor Predisposition Syndrome;Rhabdomyosarcoma;Rothmund-Thomson Syndrome;Tuberous Sclerosis;Von Hippel-Lindau Disease
- United States
- 2017-02-08
Recruiting
- Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
- Cirrhosis;Fibrosis;Hepatocellular Carcinoma;Phosphorylated Epidermal Growth Factor Receptor
- United States
- 2014-10-22
Recruiting
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
- Amyotrophic Lateral Sclerosis (ALS);Myasthenia Gravis;Myopathies;Stroke;Parkinson's Disease
- United States
- 2014-04-08
Recruiting
- Innovative Ultrasound Technology in Neuromuscular Disease
- Amyotrophic Lateral Sclerosis;Muscular Dystrophy;Radiculopathy;Myopathy;Polyneuropathy and Mononeuropathies
- United States
- 2014-03-31
Recruiting
- Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRa-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer
- Estrogen Receptor Negative;HER2/Neu Negative;Progesterone Receptor Negative;Recurrent Breast Carcinoma;Recurrent Fallopian Tube Carcinoma;Recurrent Ovarian Carcinoma;Recurrent Primary Peritoneal Carcinoma;Recurrent Uterine Corpus Carcinoma;Triple-Negative Breast Carcinoma;Folate Receptor Alpha Positive;Estrogen Receptor Negative;HER2/Neu Negative;Progesterone Receptor Negative;Recurrent Breast Carcinoma;Recurrent Fallopian Tube Carcinoma;Recurrent Ovarian Carcinoma;Recurrent Primary Peritoneal Carcinoma;Recurrent Uterine Corpus Carcinoma;Triple-Negative Breast Carcinoma;Folate Receptor Alpha Positive
- United States
- 2016-12-15
Recruiting
- Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
- Acquired Immune Deficiency Syndrome Virus;Acquired Immunodeficiency Syndrome Virus;AIDS Virus;Human Immunodeficiency Virus;Human Immunodeficiency Viruses
- United States
- 2013-10-30
Recruiting
- Swallowing skill training in neurodegenerative disease.
- Amyotrophic Lateral Sclerosis;Motor Neurone Disease;Huntington's Disease;Dysphagia
- New Zealand, United States of America
- 2017-09-01
Recruiting
- RGX-111 Gene Therapy in Patients With MPS I
- Mucopolysaccharidosis Type I (MPS I);Mucopolysaccharidosis Type I (MPS I)
- United States
- 2018-06-18
Recruiting
- Investigation on the Cortical Communication (CortiCom) System
- Tetraplegia;Locked-in Syndrome;Brainstem Stroke;Amyotrophic Lateral Sclerosis
- United States
- 2018-05-21
Recruiting
- Study of ALS Reversals 2: Genetic Analyses
- Amyotrophic Lateral Sclerosis;Progressive Muscular Atrophy
- United States
- 2018-03-08
Recruiting
- Optimizing Left Ventricular Lead To Improve Cardiac Output
- Ischemic Congestive Cardiomyopathy;Dilated Cardiomyopathy;Congestive Heart Failure
- United States
- 2011-06-16
Recruiting
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- Interstitial Lung Disease;Cystic Fibrosis;Pulmonary Hypertension;NSIP;Alpha 1-Antitrypsin Deficiency;Interstitial Lung Disease;Cystic Fibrosis;Pulmonary Hypertension;NSIP;Alpha 1-Antitrypsin Deficiency
- United States
- 2011-01-09
Recruiting
- Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
- Neurodegenerative Diseases;Amyotrophic Lateral Sclerosis;Multiple Sclerosis;Parkinson Disease
- United States
- 2013-03-30
Recruiting
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Acute Lymphoblastic Leukemia;Lymphoblastic Lymphoma;Philadelphia Chromosome Positive
- United States
- 2017-01-10
Recruiting
- Brentuximab Vedotin, Cyclosporine, and Verapamil in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Recurrent Hodgkin Lymphoma;Refractory Hodgkin Lymphoma;CD30-Positive Neoplastic Cells Present
- United States
- 2017-01-04
Recruiting
- Olaparib in Treating Patients With Metastatic or Advanced Urothelial Cancer With DNA-Repair Defects
- Abnormal DNA Repair;ATM Gene Mutation;ATR Gene Mutation;BAP1 Gene Mutation;BARD1 Gene Mutation;BLM Gene Mutation;BRCA1 Gene Mutation;BRCA2 Gene Mutation;BRIP1 Gene Mutation;CHEK1 Gene Mutation;CHEK2 Gene Mutation;FANCC Gene Mutation;FANCD2 Gene Mutation;FANCE Gene Mutation;FANCF Gene Mutation;MEN1 Gene Mutation;Metastatic Urothelial Carcinoma;MLH1 Gene Mutation;MSH2 Gene Mutation;MSH6 Gene Mutation;MUTYH Gene Mutation;NPM1 Gene Mutation;PALB2 Gene Mutation;PMS2 Gene Mutation;POLD1 Gene Mutation;POLE Gene Mutation;PRKDC Gene Mutation;RAD50 Gene Mutation;RAD51 Gene Mutation;SMARCB1 Gene Mutation;Stage III Bladder Urothelial Carcinoma AJCC v6 and v7;Stage IV Bladder Urothelial Carcinoma AJCC v7;STK11 Gene Mutation;Urothelial Carcinoma
- United States
- 2017-12-15
Recruiting
- Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
- C9orf72 Amyotrophic Lateral Sclerosis (ALS);Frontotemporal Dementia
- United States
- 2020-01-03
